Search results
The FDA Now Wants Fall COVID Vaccines to Target KP.2—But Not All Manufacturers Can Pivot
Verywell Health via Yahoo News· 3 days agoLess than a week after telling COVID-19 vaccine manufacturers to target the JN.1 variant this fall,...
Kansas sues Pfizer over 'misrepresentations' and 'adverse events' of COVID-19 vaccine
FOX Business· 6 days agoThe State of Kansas has filed a lawsuit against Pfizer, Inc. for alleged consumer protection...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 3 days agoFurther, Moderna confirmed it's in discussions with the U.S. government to move forward with its...
Moderna Stock Soars on Cutting-Edge Personalized Cancer Vaccines | Investing.com
Investing.com· 6 days agoStocks Analysis by MarketBeat.com (Jea Yu) covering: Merck & Company Inc, Amgen Inc, Biogen Inc,...
Novavax Seeks FDA Nod for Updated COVID-19 Vaccine - Novavax (NASDAQ:NVAX), Moderna (NASDAQ:MRNA)
Benzinga· 5 days agoNovavax's filing is based on guidance from the FDA issued last week, which advised COVID-19 vaccine...
Moderna shares rise as Argus lifts price target to $150 By Investing.com
Investing.com· 3 days agoThe firm's decision follows the U.S. Food and Drug Administration's (FDA) approval of Moderna's...
Moderna stock is lone omen of bird flu pandemic
Reuters· 6 days agoThe recent rise of Moderna’s stock tells a grim tale. The $56 billion company which pioneered a Covid vaccine has seen its market value rise 40% since...
Gateway - Quartz
Quartz· 6 days agoModerna stock rose after new data suggested that its experimental vaccine could be used to treat a variety of cancers. The American Society of Health-System ...
Moderna Stock (NASDAQ:MRNA): Is There Life Beyond Disease Outbreaks?
TipRanks via Yahoo Finance· 6 days agoModerna (NASDAQ:MRNA) stock has surged 40.8% since the turn of the year. Some of this momentum can...
25,274 Shares in Moderna, Inc. (NASDAQ:MRNA) Bought by Los Angeles Capital Management LLC
ETF DAILY NEWS· 2 days agoLos Angeles Capital Management LLC acquired a new position in shares of Moderna, Inc. (NASDAQ:MRNA – Free Report) during the 1st quarter, according to its most recent 13F ...